{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:58:16Z","timestamp":1777564696568,"version":"3.51.4"},"reference-count":21,"publisher":"Medical Association of Nippon Medical School","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nippon Med Sch"],"published-print":{"date-parts":[[2024,12,25]]},"DOI":"10.1272\/jnms.jnms.2024_91-602","type":"journal-article","created":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T22:15:50Z","timestamp":1735251350000},"page":"548-553","source":"Crossref","is-referenced-by-count":1,"title":["Intravenous Unfractionated Heparin vs. Therapeutic Plasma Exchange in Patients with Autoimmune Disease with Acute Thrombotic Events: Sampling in a Case of Catastrophic Antiphospholipid Syndrome"],"prefix":"10.1272","volume":"91","author":[{"given":"Yi-Ling","family":"Lin","sequence":"first","affiliation":[{"name":"School of Medicine, China Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiung-Hsiun","family":"Liu","sequence":"additional","affiliation":[{"name":"School of Medicine, China Medical University"},{"name":"Division of Nephrology and Kidney Institute, Department of Internal Medicine, China Medical University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"21","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Rosenberg RD, Rosenberg JS. Natural anticoagulant mechanisms. J Clin Invest. 1984 Jul;74:1-6.","DOI":"10.1172\/JCI111389"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Ofosu FA, Sie P, Modi GJ, et al. The inhibition of thrombin-dependent positive-feedback reactions is critical to the expression of the anticoagulant effect of heparin. Biochem J. 1987 Apr 15;243:579-88.","DOI":"10.1042\/bj2430579"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Cordoba JP, Larrarte C, Estrada C, Fernandez-Avila DG. Therapeutic plasma exchange in rheumatic diseases: a university hospital experience. Rev Bras Reumatol Engl Ed. 2017 Sep-Oct;57:397-402.","DOI":"10.1016\/j.rbre.2017.01.003"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Zoller B, Li X, Sundquist J, Sundquist K. Risk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow-up study from Sweden. Lancet. 2012 Jan 21;379:244-9.","DOI":"10.1016\/S0140-6736(11)61306-8"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Ramagopalan SV, Wotton CJ, Handel AE, Yeates D, Goldacre MJ. Risk of venous thromboembolism in people admitted to hospital with selected immune-mediated diseases: record-linkage study. BMC Med. 2011 Jan 10;9:1.","DOI":"10.1186\/1741-7015-9-1"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Rietveld IM, Lijfering WM, le Cessie S, et al. High levels of coagulation factors and venous thrombosis risk: strongest association for factor VIII and von Willebrand factor. J Thromb Haemost. 2019 Jan;17:99-109.","DOI":"10.1111\/jth.14343"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Erkan D. Therapeutic and prognostic considerations in catastrophic antiphospholipid syndrome. Autoimmun Rev. 2006 Dec;6:98-103.","DOI":"10.1016\/j.autrev.2006.06.013"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Padmanabhan A, Connelly-Smith L, Aqui N, et al. Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis: the eighth special issue. J Clin Apher. 2019 Jun;34:171-354.","DOI":"10.1002\/jca.21705"},{"key":"9","unstructured":"9. Kaplan AA. A simple and accurate method for prescribing plasma exchange. ASAIO Trans. 1990 Jul-Sep;36:M597-9."},{"key":"10","unstructured":"10. Inkley SR, Brooks L, Krieger H. A study of methods for the prediction of plasma volume. J Lab Clin Med. 1955 Jun;45:841-50."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Carmi O, Berla M, Shoenfeld Y, Levy Y. Diagnosis and management of catastrophic antiphospholipid syndrome. Expert Rev Hematol. 2017 Apr;10:365-74.","DOI":"10.1080\/17474086.2017.1300522"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Bortolati M, Marson P, Fabris F, et al. Recovery from catastrophic antiphospholipid syndrome by a plasma exchange procedure: report of four cases and review of the literature. Autoimmun Rev. 2009 Feb;8:297-301.","DOI":"10.1016\/j.autrev.2008.09.002"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Asherson RA, Cervera R, Piette JC, et al. Catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50 patients. Medicine (Baltimore). 1998 May;77:195-207.","DOI":"10.1097\/00005792-199805000-00005"},{"key":"14","doi-asserted-by":"publisher","unstructured":"14. Asherson RA, Cervera R, de Groot PG, et al. Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus. 2003;12:530-4.","DOI":"10.1191\/0961203303lu394oa"},{"key":"15","unstructured":"15. Rodriguez-Pinto I, Espinosa G, Erkan D, Shoenfeld Y, Cervera R; CAPS Registry Project Group. The effect of triple therapy on the mortality of catastrophic anti-phospholipid syndrome patients. Rheumatology (Oxford). 2018 Jul 1;57:1264-70."},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Gomez-Puerta JA, Espinosa G, Cervera R. Catastrophic antiphospholipid syndrome: diagnosis and management in pregnancy. Clin Lab Med. 2013 Jun;33:391-400.","DOI":"10.1016\/j.cll.2013.01.003"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Rodriguez-Pinto I, Cervera R, Espinosa G. Rituximab and its therapeutic potential in catastrophic antiphospolipid syndrome. Ther Adv Musculoskelet Dis. 2015 Feb;7:26-30.","DOI":"10.1177\/1759720X14554793"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Azzopardi N, Francois M, Laurent E, Paintaud G, Birmele B. Influence of plasma exchange on rituximab pharmacokinetics. Br J Clin Pharmacol. 2013 Sep;76:486-8.","DOI":"10.1111\/bcp.12167"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Kaplan A, Raut P, Totoe G, Morgan S, Zantek ND. Management of systemic unfractionated heparin anticoagulation during therapeutic plasma exchange. J Clin Apher. 2016 Dec;31:507-15.","DOI":"10.1002\/jca.21441"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Hodulik KL, Root AG, Ledbetter LS, Onwuemene OA. Effects of therapeutic plasma exchange on anticoagulants in patients receiving therapeutic anticoagulation: a systematic review. Transfusion. 2019 May;59:1870-9.","DOI":"10.1111\/trf.15191"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Cohen H, Efthymiou M, Devreese KMJ. Monitoring of anticoagulation in thrombotic antiphospholipid syndrome. J Thromb Haemost. 2021 Apr;19:892-908.","DOI":"10.1111\/jth.15217"}],"container-title":["Journal of Nippon Medical School"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jnms\/91\/6\/91_JNMS.2024_91-602\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,28]],"date-time":"2024-12-28T05:05:32Z","timestamp":1735362332000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jnms\/91\/6\/91_JNMS.2024_91-602\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,25]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1272\/jnms.jnms.2024_91-602","relation":{},"ISSN":["1345-4676","1347-3409"],"issn-type":[{"value":"1345-4676","type":"print"},{"value":"1347-3409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,25]]},"article-number":"JNMS.2024_91-602"}}